Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
701.00    0.00 (0.00%)
Bid:
692.00
Ask:
710.00
Spread: 18.00 (2.601%)
Market Cap: £247.03m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

Director/PDMR Shareholding

11 Jun 2025 16:18

RNS Number : 4594M
B.P. Marsh & Partners PLC
11 June 2025
 

11 June 2025

 

 

B.P. Marsh & Partners Plc

("B.P. Marsh" or the "Company")

 

PDMR and Director Dealings

 

B.P. Marsh (AIM: BPM), the specialist investor in early-stage financial services businesses, announces that it has been notified that Mr. Dan Topping, Chief Investment Officer, and his daughter, Felicity Topping, have purchased an aggregate of 3,739 ordinary shares of 10 pence each in the Company ("Ordinary Shares").

 

The Company has been made aware that on 10 June 2025 Mr. Topping and Felicity Topping purchased 2,337 Ordinary Shares for 641.60p per share and 1,402 Ordinary Shares for 641.60p per share, respectively, for an aggregate of £23,989.42. As a result of the transaction, Mr. Topping has a beneficial interest in 146,020 Ordinary Shares (including 14,594 Ordinary Shares owned by Persons Closely Associated with Mr. Topping), together with a beneficial interest in 17,375 Ordinary Shares held in the Company's SIP Trust, representing in aggregate approximately 0.73% of the total voting rights of the Company.

 

Additionally, Mr. Topping, as part of the Company's Joint Share Ownership Plan, has a beneficial interest (as a joint owner alongside JTC Employer Solutions Trustee) over 123,715 Ordinary Shares, representing approximately 0.45% of the total voting rights of the Company.

 

Furthermore, Mr. Topping has options over 310,000 Ordinary Shares as part of the Company's Share Option Plan announced on 20th November 2023.

 

The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Daniel Topping

2

Reason for notification

a)

Position / status

Investment Officer, PDMR

b)

Initial notification / amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

B.P. Marsh & Partners Plc

b)

LEI

2138008G8EPE3HAHEM13

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 10 pence each

Identification code

ISIN: GB00B0XLRJ79

b)

Nature of the transaction

Purchase of Ordinary Shares via SIPP

c)

Price(s) and volumes(s)

 

Price(s)

£6.4160

Volume(s)

2,337

d)

Aggregated information

N/A

e)

Date of the transaction

2025-06-10

f)

Place of the transaction

London Stock Exchange, AIM (XLON)

 

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Felicity Topping

2

Reason for notification

a)

Position / status

Person Closely Associated with Daniel Topping, Chief Investment Officer, PDMR

b)

Initial notification / amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

B.P. Marsh & Partners Plc

b)

LEI

2138008G8EPE3HAHEM13

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 10 pence each

Identification code

ISIN: GB00B0XLRJ79

b)

Nature of the transaction

Purchase of Ordinary Shares via JISA

c)

Price(s) and volumes(s)

 

Price(s)

£6.4160

Volume(s)

1,402

d)

Aggregated information

N/A

e)

Date of the transaction

2025-06-10

f)

Place of the transaction

London Stock Exchange, AIM (XLON)

 

 

 

For further information on B.P. Marsh, its strategy and current portfolio, please visit www.bpmarsh.co.uk or contact: 

 

B.P. Marsh & Partners Plc

Brian Marsh OBE / Alice Foulk

 

+44 (0)20 7233 3112

Nominated Adviser & Joint Corporate Broker:

Panmure Liberum Limited

Atholl Tweedie / Amrit Mahbubani / Ailsa MacMaster

 

+44 (0)20 7886 2500

Joint Corporate Broker:

Singer Capital Markets Advisory LLP

Charles Leigh Pemberton / James Moat / Asha Chotai

 

+44 (0)20 7496 3000

Financial PR & Investor Relations:

Tavistock

Simon Hudson / Katie Hopkins / Kuba Stawiski

 

bpmarsh@tavistock.co.uk

+44 (0)20 7920 3150

 

- Ends -

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBUGDLLBBDGUB
Date   Source Headline
28th Oct 20107:00 amRNSHalf Yearly Report
24th Sep 20107:00 amRNSNotice of Interim Results
22nd Jul 20102:23 pmRNSCompletion of U.S. Risk (UK) Limited Investment
21st Jul 201012:28 pmRNSResult of AGM
22nd Jun 20109:35 amRNSReplacement - Notice of Annual General Meeting
22nd Jun 20107:00 amRNSNotice of Annual General Meeting
10th Jun 201011:05 amRNSReplacement - Investment in U.S. Risk (UK) Limited
10th Jun 20107:00 amRNSInvestment in U.S. Risk (UK) Limited
9th Jun 20103:22 pmRNSDirectors' Loan
2nd Jun 20107:00 amRNSFinal Results
7th May 20107:00 amRNSNotice of Final Results
21st Jan 20107:00 amRNSDisposal
21st Jan 20107:00 amRNSAcquisition
11th Jan 201012:25 pmRNSDirector's Dealing
14th Dec 200910:16 amRNSDirector's Dealing
27th Oct 20097:00 amRNSInterim Results
26th Oct 20093:26 pmRNSHolding(s) in Company
30th Sep 20097:00 amRNSNotice of Interim Results
23rd Jul 200910:41 amRNSAnnual Report and Accounts
21st Jul 20097:00 amRNSResult of AGM
18th Jun 20094:07 pmRNSNotice of AGM
9th Jun 20099:28 amRNSInvestee Company, Hyperion, Announces Acquisition
3rd Jun 20097:00 amRNSLoans to Investee Company
3rd Jun 20097:00 amRNSFinal Results
18th May 20099:52 amRNSChange of Adviser
6th May 200910:58 amRNSNotice of Results
6th Apr 20093:40 pmRNSHolding(s) in Company
26th Mar 200910:11 amRNSHolding of Shares by a Director
2nd Feb 20097:00 amRNSDirectorate Change
9th Dec 20084:23 pmRNSDirector/PDMR Shareholding
4th Dec 20083:26 pmRNSDirectorate Change
3rd Dec 20084:53 pmRNSDirector/PDMR Shareholding
1st Dec 20083:05 pmRNSChange of Registered Office
18th Nov 20083:06 pmRNSDirector/PDMR Shareholding
12th Nov 200812:42 pmRNSDirector/PDMR Shareholding
28th Oct 20087:00 amRNSInterim Results
6th Oct 20082:16 pmRNSNotice of Interim Results
1st Oct 20087:00 amRNSAppointment of Nominated Adviser
24th Jul 20082:24 pmRNSResult of AGM
25th Jun 20087:00 amRNSNotice of AGM
5th Jun 20087:00 amRNSFinal Results
7th May 20082:33 pmRNSNotice of Results
2nd Apr 20089:05 amRNSHyperion partners with 3i
20th Mar 20087:00 amRNSInvestment in Trillium
11th Mar 20087:01 amRNSInvestment in Business Broker
25th Feb 20084:17 pmRNSDirectorate Change
14th Feb 20081:26 pmRNSFurther re: Disposal
12th Feb 20087:01 amRNSDisposal
4th Feb 20082:46 pmRNSIncreased Investment in Summa
27th Nov 20077:01 amRNSBoard Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.